Immediate Risk Stratification and Cardiac Stress Testing Required
This patient requires urgent cardiovascular risk stratification with stress testing (nuclear, echo, or CMR) or coronary CT angiography, as she presents with intermediate-to-high probability acute coronary syndrome features despite negative initial troponin, and her medication non-adherence significantly elevates her cardiovascular risk. 1
Critical Clinical Context
This 66-year-old woman presents with several concerning features that demand aggressive evaluation:
- Exertional symptoms (burning chest pain + dyspnea with exertion) are classic anginal equivalents, particularly in women who frequently present atypically 1, 2
- Two-week duration suggests subacute coronary syndrome rather than benign etiology
- Medication non-adherence including antihypertensives creates uncontrolled cardiovascular risk factors
- Single negative troponin is insufficient - does not exclude unstable angina or evolving ACS
Immediate Management Algorithm
1. Serial Troponin Monitoring
- Obtain high-sensitivity troponin at 0 and 3 hours minimum
- Single negative troponin does NOT exclude ACS in this intermediate-risk patient 1
2. Repeat ECG Assessment
- Obtain ECG during symptomatic episodes if possible
- Look specifically for dynamic ST-segment changes, T-wave inversions, or new Q waves
- Women are more likely to have non-ST elevation presentations 1
3. Objective Ischemia Testing (Choose ONE based on local availability):
Preferred options per 2021 ACC/AHA guidelines 1:
- Stress echocardiography with dobutamine (if she cannot exercise adequately)
- Stress nuclear imaging (SPECT or PET)
- Stress cardiac MRI (if available)
- Coronary CT angiography (CCTA) - excellent for ruling out obstructive CAD
She is NOT a candidate for exercise ECG alone because:
- Baseline ECG abnormalities may be present from uncontrolled hypertension
- Women have higher false-positive rates with exercise ECG
- Her ability to achieve ≥5 METs is uncertain given exertional dyspnea 1
4. Blood Pressure Management
- Measure current blood pressure immediately
- Severe hypertension (≥200/110 mmHg) is a contraindication to stress testing 1
- Restart antihypertensive therapy urgently - medication non-adherence is modifiable and dangerous 3
Sex-Specific Considerations
Women with chest pain face unique diagnostic challenges 2:
- Higher rates of MINOCA (myocardial infarction with non-obstructive coronary arteries)
- Spontaneous coronary artery dissection (SCAD) - more common in women
- Microvascular dysfunction - may require invasive coronary function testing if initial workup is negative
- Takotsubo syndrome - stress-induced cardiomyopathy
Critical Pitfalls to Avoid
Do NOT discharge with negative troponin alone - this is inadequate risk stratification for intermediate-probability ACS 1
Do NOT attribute symptoms to GERD or anxiety without objective cardiac testing - "burning" chest pain can be anginal equivalent, especially in women 1
Do NOT delay testing because exam is normal - absence of murmurs/rubs/gallops does not exclude ischemia
Address medication non-adherence immediately - uncontrolled hypertension dramatically increases her acute and chronic cardiovascular risk 3
If Stress Testing is Negative
Consider alternative diagnoses only after cardiac causes excluded:
- Pulmonary embolism (use Wells criteria for risk stratification) 4
- Aortic dissection (if clinical features suggest)
- Neuropathic pain (thoracic radiculopathy) 5
- Esophageal disorders
Disposition Decision
Admit or observe if:
- Any troponin elevation
- Dynamic ECG changes
- Inability to complete outpatient stress testing within 72 hours
- Uncontrolled hypertension requiring IV therapy
Outpatient stress testing (within 72 hours) only if:
- Serial troponins definitively negative
- ECG remains normal
- Blood pressure controlled
- Patient reliable for follow-up
- No high-risk features on risk stratification
The combination of exertional symptoms, female sex, age 66, and medication non-adherence places this patient at intermediate-to-high pretest probability for obstructive CAD requiring definitive anatomic or functional cardiac testing. 1